Chicago, IL · Founded 2019 · Privately Held (backing)
Operator of a biopharmaceutical company intended to discover and develop next-generation medicines for neurodegenerative diseases. Vanqua Bio is based in Chicago, IL and was founded in 2019. Its last known valuation is $270 million. It has raised $149 million across 2 recorded rounds; the latest was a $45 million early-stage round in Feb 2024.
Last price · $/share
—
Implied valuation
$270.0M
Total raised
$149.0M
Last round
Early Stage VC
Feb 2024
No prints on record
No secondary trades in Vanqua Bio shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Vanqua Bio with a free account
·The complete investor list: 12 names
·Watch Vanqua Bio: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Vanqua Bio stock.
